-
公开(公告)号:US07951798B2
公开(公告)日:2011-05-31
申请号:US10553908
申请日:2004-04-22
IPC分类号: A61P25/18 , A61K31/551 , C07D495/04
CPC分类号: C07D495/04
摘要: The present invention relates to new crystalline forms I, II and III of 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]-benzodiazepine hydrochloride, a process for the preparation thereof and pharmaceutical compositions containing the same. Said new polymorphic forms are useful as active ingredients for the treatment of psychotic conditions.
摘要翻译: 本发明涉及2-甲基-4-(4-甲基哌嗪-1-基)-10H-噻吩并[2,3-b] [1,5] - 苯并二氮杂盐酸盐的新结晶形式I,II和III, 其制备方法和含有该组合物的药物组合物。 所述新的多晶型物可用作治疗精神病状态的活性成分。